DE69733694D1 - Verwendung von proteinen aus der mk familie als hämatopoietischer faktor - Google Patents
Verwendung von proteinen aus der mk familie als hämatopoietischer faktorInfo
- Publication number
- DE69733694D1 DE69733694D1 DE69733694T DE69733694T DE69733694D1 DE 69733694 D1 DE69733694 D1 DE 69733694D1 DE 69733694 T DE69733694 T DE 69733694T DE 69733694 T DE69733694 T DE 69733694T DE 69733694 D1 DE69733694 D1 DE 69733694D1
- Authority
- DE
- Germany
- Prior art keywords
- family
- hematopoietic
- csf
- proteins
- hematopoietic factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/14—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19853196 | 1996-07-10 | ||
JP19853196 | 1996-07-10 | ||
PCT/JP1997/002401 WO1998001151A1 (fr) | 1996-07-10 | 1997-07-10 | Nouvelle utilisation de la famille mk comme facteur hematopoietique |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69733694D1 true DE69733694D1 (de) | 2005-08-11 |
DE69733694T2 DE69733694T2 (de) | 2006-07-06 |
Family
ID=16392704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69733694T Expired - Fee Related DE69733694T2 (de) | 1996-07-10 | 1997-07-10 | Verwendung von proteinen aus der mk familie als hämatopoietischer faktor |
Country Status (6)
Country | Link |
---|---|
US (2) | US6383480B1 (de) |
EP (1) | EP0937461B1 (de) |
AT (1) | ATE299030T1 (de) |
CA (1) | CA2260014A1 (de) |
DE (1) | DE69733694T2 (de) |
WO (1) | WO1998001151A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10158188A (ja) * | 1996-11-29 | 1998-06-16 | Senju Pharmaceut Co Ltd | 角膜治療用組成物 |
ATE330620T1 (de) | 1997-07-14 | 2006-07-15 | Takashi Muramatsu | Verwendung von midkin oder von anti-midkin antikörper |
US8771663B2 (en) | 2000-04-18 | 2014-07-08 | Gentium Spa | Formulation having mobilising activity |
EP1147777A1 (de) * | 2000-04-18 | 2001-10-24 | Crinos Industria Farmacobiologica S.p.A. | Kombination von Defibrotid und G-CSF und ihre Verwendung zur Aktivierung der hämatopoiestischen Vorläuferzellen |
US20040044300A1 (en) * | 2002-09-03 | 2004-03-04 | Donnie Rudd | Method of replenishing cells damaged by treatment for cancer |
US20040076605A1 (en) * | 2002-09-03 | 2004-04-22 | Donnie Rudd | Method of regenerating human tissue |
US20040043009A1 (en) * | 2002-09-03 | 2004-03-04 | Donnie Rudd | Method of repairing primate mammalian tissue |
US20040042997A1 (en) * | 2002-09-03 | 2004-03-04 | Donnie Rudd | Method of regenerating human tissue |
US20040076620A1 (en) * | 2002-09-03 | 2004-04-22 | Donnie Rudd | Method of repairing primate mammalian tissue |
US20040077985A1 (en) * | 2002-09-03 | 2004-04-22 | Donnie Rudd | Method of replenishing cells damaged by treatment for cancer |
FR2853663B1 (fr) * | 2003-04-14 | 2007-08-31 | Aventis Pharma Sa | Procede d'obtention de lignees de mastocytes a partir de tissus de porcs et procede de production de molecules de type heparine |
JP4651282B2 (ja) * | 2004-01-21 | 2011-03-16 | 田辺三菱製薬株式会社 | 造血幹細胞及び造血前駆細胞の増幅方法 |
EP1773981A1 (de) * | 2004-07-12 | 2007-04-18 | Sorin Group Italia S.R.L. | Vorrichtung und verfahren zur anzucht menschlicher zellen |
AU2005272920B2 (en) | 2004-08-10 | 2011-05-12 | Institute For Multiple Myeloma And Bone Cancer Research | Methods of regulating differentiation and treating of multiple myeloma |
JP4791770B2 (ja) * | 2004-12-06 | 2011-10-12 | 株式会社セルシグナルズ | 心筋障害又は心不全の治療もしくは予防組成物 |
US20070131375A1 (en) * | 2005-12-09 | 2007-06-14 | Husky Injection Molding Systems Ltd. | Thixo-molding shot located downstream of blockage |
WO2010036373A2 (en) * | 2008-09-26 | 2010-04-01 | Duke University | Hematopoietic stem cell growth factor |
AU2010363814B2 (en) | 2010-11-12 | 2016-05-19 | Gentium S.R.L. | Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD). |
AU2012383169B2 (en) | 2012-06-22 | 2017-12-21 | Gentium S.R.L. | Euglobulin-based method for determining the biological activity of defibrotide |
JP2016507066A (ja) | 2013-02-08 | 2016-03-07 | インスティテュート フォー ミエローマ アンド ボーン キャンサー リサーチ | 多発性骨髄腫、慢性リンパ球性白血病、およびb細胞非ホジキンリンパ腫の改善された診断方法、予後予測方法、およびモニタリング方法 |
EP3026122A1 (de) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid |
ES2898329T3 (es) | 2016-01-12 | 2022-03-07 | Oncotracker Inc | Métodos mejorados para supervisar el estado inmunitario de un sujeto |
US11635435B2 (en) | 2017-06-13 | 2023-04-25 | Oncotracker, Inc. | Diagnostic, prognostic, and monitoring methods for solid tumor cancers |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868119A (en) | 1986-12-11 | 1989-09-19 | Genetics Institute, Inc. | Hematopoietic growth factors |
ATE92966T1 (de) * | 1986-05-06 | 1993-08-15 | Genetics Inst | Herstellung von m-csf. |
US5087570A (en) * | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
US5087448A (en) * | 1989-02-02 | 1992-02-11 | The Board Of Regents Of The University Of Oklahoma | Enhancing growth of megakaryocytes in mammals using interleuking 6 |
US5437994A (en) * | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5210026A (en) * | 1990-08-20 | 1993-05-11 | American Cyanamid Company | Human mk gene and method of expression |
FR2666477A1 (fr) | 1990-08-31 | 1992-03-06 | Sodern | Tube neutronique a flux eleve. |
CA2071479A1 (en) | 1990-10-12 | 1992-04-13 | Pamela Hunt | Megakaryocyte maturation factors |
WO1992018615A1 (en) * | 1991-04-09 | 1992-10-29 | Indiana University Foundation | System and process for supporting hematopoietic cells |
EP0535336A3 (en) * | 1991-09-30 | 1993-05-19 | American Cyanamid Company | Mk protein as cell growth inhibitor |
US5461029A (en) | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
DE4240635C2 (de) * | 1992-12-03 | 1997-07-10 | Lothar Prof Dr Kanz | Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren |
AU8014694A (en) * | 1993-10-07 | 1995-05-01 | Systemix, Inc. | Methods for analysis of human stem cells |
-
1997
- 1997-07-10 CA CA002260014A patent/CA2260014A1/en not_active Abandoned
- 1997-07-10 WO PCT/JP1997/002401 patent/WO1998001151A1/ja active IP Right Grant
- 1997-07-10 EP EP97930756A patent/EP0937461B1/de not_active Expired - Lifetime
- 1997-07-10 AT AT97930756T patent/ATE299030T1/de not_active IP Right Cessation
- 1997-07-10 US US09/214,569 patent/US6383480B1/en not_active Expired - Lifetime
- 1997-07-10 DE DE69733694T patent/DE69733694T2/de not_active Expired - Fee Related
-
2002
- 2002-02-08 US US10/071,039 patent/US6939669B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3459397A (en) | 1998-02-02 |
AU733451B2 (en) | 2001-05-17 |
DE69733694T2 (de) | 2006-07-06 |
EP0937461A1 (de) | 1999-08-25 |
WO1998001151A1 (fr) | 1998-01-15 |
EP0937461B1 (de) | 2005-07-06 |
US6383480B1 (en) | 2002-05-07 |
US6939669B2 (en) | 2005-09-06 |
CA2260014A1 (en) | 1998-01-15 |
ATE299030T1 (de) | 2005-07-15 |
US20020132984A1 (en) | 2002-09-19 |
EP0937461A4 (de) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69733694D1 (de) | Verwendung von proteinen aus der mk familie als hämatopoietischer faktor | |
DE69527540D1 (de) | Verwendung von stammzellenfaktor und löslichen interleukin-6-rezeptor zur vermehrung der hämatopoietischen vorläuferzellen | |
CA2150016A1 (en) | Pyrrolopyrimidines as CRF Antagonists | |
DE69434213D1 (de) | Verwendung von Zusatzstoffen in Treibstoffzusammensetzungen | |
DE69432409D1 (de) | Verwendung der NDV zur Herstellung eines Medikaments zur Krebsbehandlung | |
FI842829A (fi) | Cykliska ureakondensat, behandlingskompositioner foer textilier och papper och nya cykliska ureafoereningar. | |
DE69917296D1 (de) | Neue substituierte triazolverbindungen | |
DE3853663D1 (de) | Plättchenförmiges Zinkoxid-Pulver und Zusammensetzung für äusserliche Verwendung. | |
DE60236016D1 (de) | Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung | |
TR200000740T2 (tr) | Dişleri beyazlatmak için metod ve kompozisyonlar. | |
RU94044324A (ru) | СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ СЛОЖНЫХ ЭФИРОВ ИЗОСЕРИНА С ИСПОЛЬЗОВАНИЕМ МЕТАЛАЛКОГОЛЯТОВ И β -ЛАКТАМОВ | |
DK1010675T3 (da) | Höjtemperaturforseglingsmateriale | |
MY115960A (en) | Method of administering crf antagonists | |
EA199900869A1 (ru) | Цитокин-подобный фактор 7 млекопитающих | |
ES2180654T3 (es) | Poliisocianatos que contienen uretidiona y alofanato. | |
IT8448944A0 (it) | Composizione contenente manganese e rame,combustibile che la contiene e relativo metodo per ridurre l'accensione di particelle di scarico | |
DE69421784D1 (de) | Kraftstoffzusammensetzungen, und Zusätze dafür | |
AR248151A1 (es) | Composicion aislante tixotropica, metodo de transporte para la misma. | |
SI1086096T1 (en) | Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors | |
HK1033096A1 (en) | Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders | |
DE69006878D1 (de) | Teilchenförmiger Reinigungsmittel-Zusatz, dessen Herstellung und Verwendung in Reinigungsmittelzusammensetzungen. | |
DE69014717D1 (de) | Stabilisierte Zusammensetzungen von Metalloxidpulver. | |
ATE30008T1 (de) | Stabilisierte zusammensetzung zur verwendung in pyrolytischer beschichtung von glas. | |
DE69112682D1 (de) | Pfropfcopolymere zur Verwendung als Hauptkomponente von der Beschichtungszusammensetzung. | |
AU8402491A (en) | Beta chain of the human gm-csf receptor and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: MURAMATSU, TAKASHI, NAGOYA, AICHI, JP |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |